CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5,005 Cr | ₹4,134 Cr | ₹3,238 Cr | ₹3,326 Cr | ₹3,755 Cr |
What is the latest Cash Flow from Operating Activities ratio of CIPLA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹5,005 Cr |
| Mar2024 | ₹4,134 Cr |
| Mar2023 | ₹3,238 Cr |
| Mar2022 | ₹3,326 Cr |
| Mar2021 | ₹3,755 Cr |
How is Cash Flow from Operating Activities of CIPLA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,005 Cr | 21.07 | |
| Mar2024 | ₹4,134 Cr | 27.68 | |
| Mar2023 | ₹3,238 Cr | -2.65 | |
| Mar2022 | ₹3,326 Cr | -11.43 | |
| Mar2021 | ₹3,755 Cr | - | |
Compare Cash Flow from Operating Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹107,401.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
| MANKIND PHARMA | ₹85,818.0 Cr | 0.9% | -6.1% | -15.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.1% |
-8.2% |
-8.3% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses